Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You're unwilling or incapable of grasping a thing I said, hard to know which.
No, I'm sure you don't see anything because it's too obvious. Better to pretend and gaslight. Over the years the two companies have diverted due to good decision making vs. bad. But the two do have in common a single disease / single platform therapeutic product with a completed Plll waiting for regulators. One chose to remain on the Nasdaq while the other did not. One chose hundreds of employees while the other went with 20. One chose to fill all top management spots with highly qualified employees while the other has lawyers without employee agreements in place. Therefore one has an institutional following while the other has a CEO CFO Chair running a private CDMO who hasn't presented to her shareholders in five years. One raises $200M while the other raises $3M.
LOL. You disciples are so FOS. This is what a cash raise looks like pre commercialization waiting on regulators, not a lousy $3M in an inflation driven environment with lots of legal bills incoming.
>>Geron stock rises after pricing $198M securities offering
Geron (NASDAQ:GERN) shares gained 6% premarket on Friday after the biopharmaceutical company priced its $198M upsized offering of 55,876,297 shares and pre-funded warrants to purchase 25M shares.
The shares are being offered at $2.45 each, while the pre-funded warrants are being sold at$2.449 each.
How about any phone calls from the proxy company that was hired? What's their pitch?
It's called a "Daily affirmation" here.
Perhaps an all expenses paid shareholder tour of Sawston given by Advent's people??
Give that man a cigar.
Bought at $2.54. Chump change.
Stop baiting poor green retail with this David & Goliath nonsense, as other promising biotechs get bought out for nice premiums. Disgraceful.
They may know it's the last thing LP wants. ??
>>I don't understand what's in the heads of the Defendants choosing to go to discovery rather than settlement.
No lies. Everything I post is my best guess on what's going down based on evidence.
Anything but nonsense. Shorts have called it right making a fortune over the past ten years. LP has the company set up to restructure or pull the plug anytime she wants. There's no sign of commercialization because they don't have the people in place unless NWBO intends to hand it all over to Advent, in which case kiss any retail shareholder return goodbye.
>>Nonsense. Shorts have said this for the last 10 years. They are at the beginning of what looks like a successful commercialization process and are well positioned to capitalize on it.
Show me.
I don't recall reading that in any filing.
>>The spoofing suit isn't costing NWBO anything, win or lose.
They already said they're on the hook for millions with this true up suit. I'm sure this new proxy battle will end up costing. Who knows what they'll need to pay the firm running the spoofing suit should they come up empty. And, we're still waiting for the true-up plaintiff's next move. I wouldn't doubt during discovery they expand their complaint. Who knows, if they're serious maybe they'll go after Advent?? I'm still uncertain as to why the leaders of NWBO let their employee contracts expire but I have some ideas.
I've never known a biotech allegedly gearing up for commercialization to be running on fumes. The cost must be enormous. Use Geron as an example.
>>They have run with very limited cash on hand for years. YEARS.
They never took loans to pay interest on loans before. $3.5M might pay for legal fees.
>>So if you think they're insolvent now, then they were insolvent for every month of every year since 2016. And yet, they're still here.
They already have loans paying off loans. At one point everyone here and Lappin thought those were bridge loans for something wonderful about to happen, but turned out not so. Instead just more breadcrumbs but with real consequences should they ever default.
This latest deal has nothing to do with analyst coverage so give it a break. Yeah, this $3.5 is gonna get LP out of her cocoon. Sure. Eye rolls.
>>I would bet they could have procured a loan for that much. Instead this company took equity. The added benefit is they do actual analysis for the markets. It benefits NWBO to start getting coverage. With this act we may start to finally see participation at investment conferences. Wouldn’t that be a change?
Still trying to harm poor green retail wallets, I see.
According to the company if they lose the true-up suit they'll need to pay millions in law fees among other things.
Yup.
>>The Company determined that the Series C Shares contain contingent redemption provisions allowing redemption by the holder upon certain defined events (“deemed liquidation events”). As the event that may trigger the redemption of the Series C Shares is not solely within the Company’s control, the Series C Shares are classified as mezzanine equity (temporary equity) in the Company’s condensed consolidated balance sheets.
No, those shares sold in the Q's are from converted options / warrant deals struck ages ago. The company has no control over whether or not those holders sell out and presumably the sellers have no knowledge of material information. For the company to strike this current deal, however, they cannot be in possession of any material information that'd drastically increase the share price.
>>They've been 'showing the cards' (aka disclosing how many shares they've sold and at what valuation) in every 10Q for the past 5 years.
Seriously? They've just shown their cards. No buyout, no partner, no near term approval. Perceived value of the company now stands roughly $500M not the $5,10,20B the disciples here have been pumping. But the market cap does sound about right for half a CMO in the UK although still way too dear, IMO, due to this management.
>>Why this particular 8 million is causing so much hubbub, I don't know.
I thought for sure they'd wait for a sleepy Friday with that news but instead they did it on Super Tuesdays. LOL.
Interesting Bigger doesn't chime in on the subject. Does he even own shares anymore?
Today's disciple trick is to get them to believe NWBO now has "Institutional holdings". LOL. You just can't make this stuff up.
No, helping to liberate retail!!!
>>helping to destroy NWBO..
LOL. When it's in the .30's you won't be calling them "geniuses", I can guarantee that. You pumpers have absolutely no shame.
You're even worse than just harmful to retail.
Now you're talking about all the things I've been laying down here for a long time just trying to get ahead of it.
Funny, no response to this poor guy.
No, I mean investors concerned with fiduciary duty.
That's what you all told me about the last deal at 82 cents. I was right, of course.
Can anyone find us an example of management seeking a massive options package while not having proper employee contracts in place? Thanks in advance.
Is it next Friday yet? .30's soon come.
Are you sure? Seems like LP's setting up a patent troll operation.
>>Their primary business is not litigation
https://www.michiganmedicine.org/health-lab/path-forward-glioblastoma-treatment
They are embarrassing. But I've come to realize that wherever the 50k genuine shareholders are - they're not here. You wonder why the lawyers used iHub as a litmus test for "positivity". Eye rolls.
That'll probably go towards paying the True-up lawfirm fees. Eye rolls.
Nice work, Takealltheriskgivethemallthe reward. You feel proud baiting so many retail?
Holding my nose on that post. This is the part where Crash attempts to normalize everything again for poor green retail.
LOL
>> asymmetric returns
What'd you accidentally copy paste that from years ago?
>> but we will have our reckoning before SDNY.
>> Oh yeah, you're elated alright. LOL
I am simply elated we have a hedge fund with medical doctor as portfolio manager buying into our company.
How embarrassing for you.
>>No doubt the first of many great deals in the next coming weeks and months.